194 related articles for article (PubMed ID: 33884652)
21. Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma.
Yim K; Won DD; Lee IK; Oh ST; Jung ES; Lee SH
World J Gastroenterol; 2017 Aug; 23(32):5936-5944. PubMed ID: 28932085
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma.
Chen L; Chen M; Han Z; Jiang F; Xu C; Qin Y; Ding N; Liu Y; Zhang T; An Z; Guo C
J Clin Pathol; 2018 Aug; 71(8):721-728. PubMed ID: 29559517
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A
Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733
[TBL] [Abstract][Full Text] [Related]
24. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue.
Inoue C; Tamatsuki D; Miki Y; Saito R; Okada Y; Sasano H
Virchows Arch; 2019 Aug; 475(2):181-189. PubMed ID: 31134329
[TBL] [Abstract][Full Text] [Related]
26. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
27. Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.
Lee SJ; Yang CS; Kim DD; Kang YN; Kwak SG; Park JB; Cho CH; Park KK
Int J Clin Exp Pathol; 2015; 8(11):14270-82. PubMed ID: 26823743
[TBL] [Abstract][Full Text] [Related]
28. Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.
Wang YW; Zhu ML; Wang RF; Xue WJ; Zhu XR; Wang LF; Zheng LZ
Tumour Biol; 2016 Jul; 37(7):8567-78. PubMed ID: 26733174
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
Ha SY; Yeo SY; Xuan YH; Kim SH
PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
[TBL] [Abstract][Full Text] [Related]
30. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.
Matsuwaki R; Ishii G; Zenke Y; Neri S; Aokage K; Hishida T; Yoshida J; Fujii S; Kondo H; Goya T; Nagai K; Ochiai A
Cancer Sci; 2014 Jul; 105(7):905-11. PubMed ID: 24814677
[TBL] [Abstract][Full Text] [Related]
32. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
[TBL] [Abstract][Full Text] [Related]
34. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
35. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
[TBL] [Abstract][Full Text] [Related]
36. Periostin
Wei WF; Chen XJ; Liang LJ; Yu L; Wu XG; Zhou CF; Wang ZC; Fan LS; Hu Z; Liang L; Wang W
Mol Oncol; 2021 Jan; 15(1):210-227. PubMed ID: 33124726
[TBL] [Abstract][Full Text] [Related]
37. Identification of Cancer-Associated Fibroblasts in Metastatic Lymph Nodes of Colorectal Carcinoma.
Oleynikova NA; Kharlova OA; Malkov PG; Danilova ND
Bull Exp Biol Med; 2023 Mar; 174(5):634-638. PubMed ID: 37043062
[TBL] [Abstract][Full Text] [Related]
38. Expression of cancer-associated fibroblast markers in advanced colorectal cancer.
Nishishita R; Morohashi S; Seino H; Wu Y; Yoshizawa T; Haga T; Saito K; Hakamada K; Fukuda S; Kijima H
Oncol Lett; 2018 May; 15(5):6195-6202. PubMed ID: 29616101
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.
Greimelmaier K; Klopp N; Mairinger E; Wessolly M; Borchert S; Steinborn J; Schmid KW; Wohlschlaeger J; Mairinger FD
Pathol Oncol Res; 2023; 29():1611163. PubMed ID: 37614665
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
